Design, synthesis and screening of antisense peptide based combinatorial peptide libraries towards an aromatic region of SARS-CoV

Journal of Molecular Recognition

Volumn 21, Issue 2, 2008, Pages 122-131

  Huang, Yanyan ^a   Zhao, Rui ^a   Luo, Jia ^a   Xiong, Shaoxiang ^a   Shangguan, Dihua ^a   Zhang, Hongwu ^a   Liu, Guoquan ^a   Chen, Yi ^a  

^a INSTITUTE OF CHEMISTRY   (China)

Author keywords

Antisense peptides; Combinatorial chemistry; High performance affinity chromatography; Potential inhibitor; SARS CoV

Indexed keywords

BUFFER; LIGAND; PEPTIDE; PEPTIDE LIBRARY; VIRUS PROTEIN;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; SARS CORONAVIRUS; SYNTHESIS;

AMINO ACID SEQUENCE; BUFFERS; CHROMATOGRAPHY, AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; SARS VIRUS; VIRAL PROTEINS;

SARS CORONAVIRUS;

EID: 42149173143     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.880     Document Type: Article

References (44)

1. Araga S, LeBoeuf RD, Blalock JE. 1993. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 90: 8747-8751.
2. Atherton E, Sheppard RC. 1989. Solid Phase Peptide Synthesis: A Practical Approach. IRL Press: Oxford.
3. Blalock JE. 1990. Complementarity of peptides specified by 'sense' and 'antisense' strands of DNA. Trends Biotechnol. 8: 140-144.
4. Blalock JE. 1995. Genetic origins of protein shape and interaction rules. Nat. Med. (N.Y.) 1: 876-878.
5. Bost KL, Blalock JE. 1989. Production of anti-idiotypic antibodies by immunization with a pair of complementary peptides. J. Mol. Recognit. 1: 179-183.
6. Broer R, Boson B, Spaan W, Cosset FL, Corver J. 2006. Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry. J. Virol. 80: 1302-1310.
7. Davids JW, El-Bakri A, Heal J, Christie G, Roberts GW, Raynes JG, Miller AD. 1997. Design of antisense (complementary) peptides as selective inhibitors of cytokine Interleukin-1. Angew. Chem. Int. Ed. Engl. 36: 962-967.
8. Dooley CT, Houghten RA. 2000. Synthesis and screening of positional scanning combinatorial libraries. Methods Mol. Biol. 87: 13-24.
9. Fassina G, Cassani G, Gnocchi P, Fornasiero MC, lsetta AM. 1995. Inhibition of interleukin-2/p55 receptor subunit interaction by complementary peptides. Arch. Biochem. Biophys. 318: 37-45.
10. Fassina G, Consonni R, Zetta L, Cassani G. 1992. Design of hydropathically complementary peptides for big endothelin affinity purification. Int. J. Pept. Protein Res. 39: 540-548.
11. Furka A, Sebestyén F, Asgedom M, Dibó G. 1991. General method for rapid synthesis of multicomponent peptide mixtures. Int. J. Pept. Protein Res. 37: 487-493.
12. Guillen J, Perez-Berna AJ, Moreno MR, Villalain J. 2005. Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism. J. Virol. 79: 1743-1752.
13. Heal JR, Roberts GW, Raynes JG, Bhakoo A, Miller AD. 2002. Specific interactions between sense and complementary peptides: the basis for the proteomic code. Chembiochem 3: 136-151.
14. Hofmann H, Hattermann K, Marzi A, Gramberg T, Geier M, Krumbiegel M, Kuate S, Liberia K, Niedrig M, Pöhlmann S. 2004. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J. Virol. 78: 6134-6142.
15. Houghten RA, Pinilla C, Blondelle SE, Appel JR, Dooley CT, Cuervo JH. 1991. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 354: 84-86.
16. Imai M, Baranyi L, Okada N, Okada H. 2007. Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments. Biochem. Biophys. Res. Commun. 353: 851-856.
17. Jeffrey GA. 1997. An Introduction to Hydrogen Bonding. Oxford University Press: New York.
18. Keen RT. 1957. Determination of oxetanes. Anal. Chem. 29: 1041-1044.
19. Lam KS, Salmon SE, Herssh EM, Hruby VJ, Kazmierski WM, Knapp RJ. 1991. A new type of synthetic peptide library for identifying ligand-binding activity. Nature 354: 82-84.
20. Lee WC, Lee KH. 2004. Applications of affinity chromatography in proteomics. Anal. Biochem. 324: 1-10.
21. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. 2003. Angiotensin-Converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426: 450-454.
22. Lowe CR. 1984. New developments in downstream processing. J. Biotechnol. 1: 3-12.
23. Luo J, Zhang QD, Huang YY, Liu GQ, Zhao R. 2007. Quartz crystal microbalance biosensor for recombinant human interferon-β detection based on antisense peptide approach. Anal. Chim. Acta 590: 91-97.
24. Mekler LB. 1969. On the specific selective interaction between amino acid residues of polypeptide chain. Biofizika 14: 581-584.
25. Peczuh MW, Hamilton AD. 2000. Peptide and protein recognition by designed molecules. Chem. Rev. 100: 2479-2494.
26. Ren Y, Blaker M, Seshadri L, McBride EW, Beinborn M, Kopin AS. 2003. Conserved cholecystokinin receptor transmembrane domain IV amino acids confer peptide affinity. J. Mol. Neurosci. 20:115-124.
27. Root-Bernstein RS. 1982. Amino acid pairing. J. Theor. Biol. 94:885-894.
28. Roque ACA, Taipa1 MA, Lowe CR. 2005. Synthesis and screening of a rationally designed combinatorial library of affinity ligands mimicking protein L from Peptostreptococcus magnus. J. Mol. Recognit. 18: 213-224.
29. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Peñaranda S, Bankamp B, Maher K, Chen M, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rassmussen M, Fouchier R, Günther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson U, Bellini WJ. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300: 1394-1399.
30. Ruiz-Opazo N, Akimoto K, Herrera VL. 1995. Identification of a novel dual angiotensin II/vasopressin receptor on the basis of molecular recognition theory. Nat. Med. 1: 1074-1081.
31. Sahagun-Ruiz A, Colla JS, Juhn J, Gao JL, Murphy PM, McDermott DH. 2001. Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRL1R. Genes Immun. 2: 335-342.
32. Sainz B Jr, Rausch JM, Gallaher WR, Garry RF, Wimley WC. 2005. The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry. Biochemistry 44: 947-958.
33. Schmuck C, Heil M. 2003. Peptide binding by one-armed receptors in water: screening of a combinatorial library for the binding of Val-Val-Ile-Ala. Chembiochem 4: 1232-1238.
34. Selz KA, Samoylova TI, Samoylov AM, Vodyanoy VJ, Mandelll AJ. 2006. Designing allosteric peptide ligands targeting a globular protein. Biopolymers 85: 38-59.
35. Shai Y, Flashner M, Chaiken IM. 1987. Anti-sense peptide recognition of sense peptides: direct quantitative characterization with the ribonuclease S-peptide system using analytical high-performance affinity chromatography. Biochemistry 26: 669-675.
36. Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P. 2004. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. U.S.A. 101: 4240-4245.
37. Stein RA, Staros JV. 2000. Evolutionary analysis of the ErbB receptor and ligand families. J. Mol. Evol. 50: 397-412.
38. Tozzi C, Anfossi L, Giraudi G. 2003. Affinity chromatography techniques based on the immobilisation of peptides exhibiting specific binding activity. J. Chromatogr. B 797: 289-304.
39. Tsang KY, Diaz H, Graciana N. 1994. Hydrophobic cluster formation is necessary for dibenzofuran-based amino acids to function as β-sheet nucleators. J. Am. Chem. Soc. 116: 3988-4005.
40. Wilson MB, Nakane PK. 1978. In Immunofluorescence and Related Staining Techniques, Knapp W, Holuber K, Wick G (eds). Elsevier: North-Holland Biomedical Press: Amsterdam; 215-224.
41. Winzor DJ. 2004. Determination of binding constants by affinity chromatography. J. Chromatogr. A 1037: 351-367.
42. Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, Subbarao K, Nabel GJ. 2004. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 78: 5642-5650.
43. Zhao R, Fang CL, Yu X, Liu Y, Luo J, Shangguan DH, Xiong SX, Su TS, Liu GQ. 2005. Screening of inhibitors for influenza A virus using high-performance affinity chromatography and combinatorial peptide library. J. Chromatogr. A 1064: 59-66.
44. Zhao R, Yu X, Liu H, Zhai LL, Xiong SX, Su TS, Liu GQ. 2001. Study on the degeneracy peptides using affinity chromatography. J. Chromatogr. A 913: 421-428.